Results 121 to 130 of about 9,455 (159)

Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine [PDF]

, 1983
Cunha-Oliveira, T., Rego, A. C., Cardoso, S. M., Borges, F., Swerdlow, R., Macedo, T., Oliveira, C. R.   +6 more
core   +1 more source

Packaging monoamine neurotransmitters. [PDF]

Cell Res
Yadav R, Gati C.
europepmc   +1 more source

Cellular mechanisms of hormone secretion in neuroendocrine tumors: what goes wrong? [PDF]

Front Cell Dev Biol
Streit L, Tanguy E, Brunaud L, Tóth P, Vitale N, Ory S, Gasman S.   +6 more
europepmc   +1 more source

Synaptic Chaperone Dysfunction as a Convergent Mechanism in Neurodegenerative and Psychiatric Disorders. [PDF]

Neurosci Insights
Jean D, Li Y.
europepmc   +1 more source

Peripheral catecholamine systems: an evolutionary perspective. [PDF]

Am J Physiol Regul Integr Comp Physiol
Goldstein DS.
europepmc   +1 more source

Decoding serotonin: the molecular symphony behind depression. [PDF]

Front Cell Neurosci
Shu Y, Tian L, Wang X, Meng T, Yu S, Li Y.   +5 more
europepmc   +1 more source

The Enigma of Neuromelanin: How Animal Models Can Help Researchers to Understand the Link Between Pigments and Neurodegeneration. [PDF]

Biomedicines
Esser S, Hausherr M, Marcus-Alic K.
europepmc   +1 more source

Functional and phylogenetic analysis of placozoan GPCRs reveal the prebilaterian origin of monoaminergic signalling

Yañez-Guerra LA, Mayorova TD, Guan L, Jékely G, Wijnen H, Senatore A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease

Experimental Neurology, 1999
The vesicular monoamine transporter (VMAT2) has been suggested to be an excellent marker of presynaptic dopaminergic nerve terminals in the striatum of Parkinson's disease patients based on its high level of expression and insensitivity to drugs used to treat the disease.
G W, Miller, J D, Erickson, J T, Perez, S N, Penland, D C, Mash, D B, Rye, A I, Levey   +6 more
openaire   +2 more sources

Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein

European Journal of Pharmacology, 2004
Recent studies demonstrate that multiple dopamine receptor subtypes contribute to the regulation of vesicular monoamine transporter-2 (VMAT-2) activity. The present studies extend these findings by demonstrating that administration of the nonselective dopamine D2 receptor family agonist, quinpirole, rapidly increased vesicular dopamine uptake in ...
Jannine G, Truong, Amy H, Newman, Glen R, Hanson, Annette E, Fleckenstein   +3 more
openaire   +2 more sources